Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the...
Year: 2022
Clover Health Beats Expectations with Medicare Advantage Membership Growing by Over 25% at the Start of 2022
Fueled by strong performance in New Jersey and GeorgiaNASHVILLE, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq:...
NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021
Technology is awarded for its advances in mental healthMALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),...
BrightInsight Announces Partnership with Sanofi to Bring to Market a Next Generation Digital Companion Application
BrightInsight’s Platform has been selected to Accelerate Continuous Development of one of Sanofi’s Best-In-Class Software as a Medical DeviceSAN JOSE,...
Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021
ROSELAND, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2022
BURNABY, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today outlined its...
Sienna Senior Living Inc. Provides Business Update and Announces Addition to its Board of Directors
MARKHAM, Ontario, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today provided...
Scopus BioPharma Provides Update Following Annual Meeting of Stockholders
Overwhelming Majority of Shares Voted by Unaffiliated Stockholderswere in Favor of Scopus' Director Nominees Lasters’ Ownership Position and Annual Meeting...
Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition
SEATTLE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) today reported preliminary, unaudited revenue for the year...
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation
IRVINE, CA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a...
Starton Therapeutics Receives Clinical Trial Authorization in Europe to Initiate Phase 1 Clinical Trial of STAR-LLD Continuous Delivery Lenalidomide
STAR-LLD is the first continuous delivery immunomodulatory drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma...
Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven Different Tumor Types and in Diabetes for BMF-219
REDWOOD CITY, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated...
Allogene Therapeutics Announces Removal of FDA Clinical Hold Across All AlloCAR T™ Clinical Trials
Investigation Confirmed the Chromosomal Abnormality in a Single Patient was Not Observed in Any AlloCAR T Product and Not Related...
Veru Announces FDA Grant of Fast Track Designation for Enobosarm for the Treatment of AR+ ER+ HER2- Metastatic Breast Cancer
-- FDA Fast Track Designation is Intended to Expedite the Development and Review of New Drugs to Treat Serious Medical...
CBD of Denver Announces Completion of 2019 and 2020 Audits
Denver, Colorado--(Newsfile Corp. - January 10, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of...
CENTR Files Amended Q1 ’22 Financials Showing Increased Net Income
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Meta Technologies Empowers Private Healthcare with Myriad Health
Myriad Health eliminates bloated corporate partnerships and crushing overhead with the first-ever truly free EHR and billing software VALHALLA, N.Y.--(BUSINESS...
QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors
ALCESTER, England & BEVERLY, Mass.--(BUSINESS WIRE)--QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a medical technology company committed to making...
Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Fourth quarter revenue expected to be in the range of $35.0 million to $35.5 million, representing growth of 30% to...